SHREVEPORT, La. - Patients diagnosed with liver cancer in the ArkLaTex now have access to a new treatment option closer to ...

Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from ...

It is poised to revolutionize cancer treatment. An experimental drug that targets pancreatic cancer is being fast tracked for ...

Stevia is widely known around the world as a natural sugar substitute used in drinks, desserts, and low-calorie foods. Many ...

Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...

Alpha Tau said it will discuss interim data on Monday from the first three patients treated in its U.S. Regain study evaluating Alpha DaRT in patients with recurrent Glioblastoma. ・Alpha DaRT uses ...

Microfluidic architecture with vascular and tumor chambers recreates perfusion and desmoplastic stroma, enabling longitudinal visualization of PDAC cell–stromal dynamics under near-physiologic flow.

Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...

Amplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in combination with standard-of-care chemotherapy Ovarian cancer represents a major target ...

Artificial intelligence detected hidden signs of pancreatic cancer in normal scans long before a medical diagnosis was made.

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas ...